B-Cell Activity Predicts Response to Glatiramer Acetate and Interferon in Relapsing-Remitting Multiple Sclerosis

OBJECTIVE: We investigated the predictive value of the enzyme-linked immunospot technique (ELISPOT) in identifying patients with relapsing-remitting multiple sclerosis (RRMS) who will respond to treatment with glatiramer acetate (GA) or interferon-β (IFN-β), based on the brain-reactive B-cell activi...

Descripción completa

Detalles Bibliográficos
Autores principales: Tacke, Sabine, Braune, Stefan, Rovituso, Damiano M., Ziemssen, Tjalf, Lehmann, Paul V., Dikow, Heidi, Bergmann, Arnfin, Kuerten, Stefanie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7958588/
https://www.ncbi.nlm.nih.gov/pubmed/33707177
http://dx.doi.org/10.1212/NXI.0000000000000980

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7958588/
https://www.ncbi.nlm.nih.gov/pubmed/33707177
http://dx.doi.org/10.1212/NXI.0000000000000980

Ejemplares similares